F Larra

1.3k total citations
39 papers, 917 citations indexed

About

F Larra is a scholar working on Oncology, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, F Larra has authored 39 papers receiving a total of 917 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Oncology, 11 papers in Pathology and Forensic Medicine and 11 papers in Pulmonary and Respiratory Medicine. Recurrent topics in F Larra's work include Colorectal Cancer Treatments and Studies (8 papers), Cancer Treatment and Pharmacology (7 papers) and Cancer Genomics and Diagnostics (7 papers). F Larra is often cited by papers focused on Colorectal Cancer Treatments and Studies (8 papers), Cancer Treatment and Pharmacology (7 papers) and Cancer Genomics and Diagnostics (7 papers). F Larra collaborates with scholars based in France. F Larra's co-authors include Érick Gamelin, M. Boisdron‐Celle, Alain Lortholary, R. Delva, A Daver, Jacques Robert, Jean-Pierre Muratet, P. Maillart, Franck Geneviève and Norbert Ifrah and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and European Journal of Cancer.

In The Last Decade

F Larra

37 papers receiving 878 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
F Larra France 13 508 205 166 161 157 39 917
D. Nagel Germany 11 405 0.8× 228 1.1× 261 1.6× 97 0.6× 279 1.8× 24 960
B.M.J. Cantwell United Kingdom 19 421 0.8× 338 1.6× 138 0.8× 68 0.4× 172 1.1× 52 1.1k
Paolo De Giuli Italy 15 454 0.9× 331 1.6× 384 2.3× 88 0.5× 251 1.6× 19 1.2k
Kenneth Newkirk United States 16 374 0.7× 270 1.3× 208 1.3× 112 0.7× 366 2.3× 25 973
Michael P. Chu Canada 21 570 1.1× 308 1.5× 246 1.5× 124 0.8× 127 0.8× 66 1.2k
S. J. Harland United Kingdom 18 390 0.8× 398 1.9× 219 1.3× 105 0.7× 410 2.6× 32 1.1k
P Cappelaere France 15 395 0.8× 140 0.7× 216 1.3× 65 0.4× 267 1.7× 66 855
Yujun Li China 17 278 0.5× 331 1.6× 239 1.4× 91 0.6× 125 0.8× 74 831
Stefan Madajewicz United States 20 875 1.7× 236 1.2× 484 2.9× 160 1.0× 349 2.2× 63 1.5k
Deborah Kilpatrick United States 15 206 0.4× 268 1.3× 163 1.0× 63 0.4× 326 2.1× 27 931

Countries citing papers authored by F Larra

Since Specialization
Citations

This map shows the geographic impact of F Larra's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F Larra with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F Larra more than expected).

Fields of papers citing papers by F Larra

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F Larra. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F Larra. The network helps show where F Larra may publish in the future.

Co-authorship network of co-authors of F Larra

This figure shows the co-authorship network connecting the top 25 collaborators of F Larra. A scholar is included among the top collaborators of F Larra based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F Larra. F Larra is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lortholary, Alain, Mireille Cossée, E. Gamelin, & F Larra. (2012). Paraneoplastic Syndromes. SpringerReference. 80(3). 177–91. 4 indexed citations
2.
Lortholary, Alain, Mireille Cossée, Érick Gamelin, & F Larra. (2011). Paraneoplastic Syndromes. PubMed. 80(4). 2784–2785. 2 indexed citations
3.
Sauvaigo, Sylvie, A Daver, Martin Pagé, et al.. (2000). Specific H-Ras minisatellite alleles in breast cancer susceptibility.. PubMed. 19(6B). 5191–6. 9 indexed citations
4.
5.
Delva, R., Érick Gamelin, Alain Lortholary, et al.. (1998). Suppression of heparinization of central venous catheters between cycles of chemotherapy. Supportive Care in Cancer. 6(4). 384–388. 5 indexed citations
6.
Gamelin, Érick, M. Boisdron‐Celle, Alain Turcant, et al.. (1998). Determination of unbound platinum after oxaliplatin administration. Anti-Cancer Drugs. 9(3). 223–228. 12 indexed citations
7.
Chassevent, Agnès, et al.. (1997). Valeur pronostique de la cytométrie en flux dans les cancers bronchiques épidermoïdes. Etude rétrospective à propos de 61 cas.. Bulletin du Cancer. 84(6). 597–602. 4 indexed citations
8.
Muratet, Jean-Pierre, et al.. (1997). Predicting the efficacy of first iodine-131 treatment in differentiated thyroid carcinoma.. PubMed. 38(9). 1362–8. 47 indexed citations
9.
Gamelin, Érick, M. Boisdron‐Celle, Alain Turcant, et al.. (1997). Rapid and sensitive high-performance liquid chromatographic analysis of halogenopyrimidines in plasma. Journal of Chromatography B Biomedical Sciences and Applications. 695(2). 409–416. 36 indexed citations
10.
Gamelin, Érick, A Cailleux, Anne Le Bouil, et al.. (1997). Plasma sialic acid as a marker of the effect of the treatment on metastatic colorectal cancer. European Journal of Cancer. 33(13). 2216–2220. 18 indexed citations
11.
Delva, R., E. Gamelin, P. Maillart, et al.. (1997). Oxaliplatin (LOHP) and 5-fluorouracil (5-FU) synergism in advanced colorectal cancer patients (ACRC). European Journal of Cancer. 33. S167–S167. 5 indexed citations
12.
Chassevent, Agnès, et al.. (1997). [Prognostic value of flow cytometry in squamous cell bronchogenic cancer. A retrospective study of 61 cases].. PubMed. 84(6). 597–602. 3 indexed citations
13.
Baudet, Christel, Guillemette Chevalier, A Chassevent, et al.. (1996). 1,25-Dihydroxyvitamin D3 induces programmed cell death in a rat glioma cell line. Journal of Neuroscience Research. 46(5). 540–550. 44 indexed citations
14.
Delva, R., P. Maillart, Alain Lortholary, et al.. (1996). [Maintenance of the dose-intensity of chemotherapy combining carboplatin, cyclophosphamide, etoposide in women with ovarian cancer aged 70 and over].. PubMed. 83(1). 63–69. 1 indexed citations
15.
Gamelin, Érick, E Danquechin‐Dorval, P. Maillart, et al.. (1996). Relationship between 5-fluorouracil (5-FU) dose intensity and therapeutic response in patients with advanced colorectal cancer receiving infusional therapy containing 5-FU. Cancer. 77(3). 441–451. 180 indexed citations
16.
Allain, Pierre, et al.. (1995). Long-term pharmacokinetic behavior of platinum after cisplatin administration. Cancer Chemotherapy and Pharmacology. 37(1-2). 97–102. 1 indexed citations
17.
Gamelin, Érick, et al.. (1995). Long-term pharmacokinetic behavior of platinum after cisplatin administration. Cancer Chemotherapy and Pharmacology. 37(1-2). 97–102. 25 indexed citations
18.
Delva, R., F Pein, Alain Lortholary, et al.. (1993). Métastases osseuses des cancers colorectaux: à propos de huit cas. La Revue de Médecine Interne. 14(4). 223–228. 8 indexed citations
19.
Daver, A, Michael R. Page, A Chassevent, et al.. (1989). Flow cytometric analysis of DNA abnormalities in colorectal carcinomas.. PubMed. 76(3). 291–300. 4 indexed citations
20.
Allain, Philippe, D Chaleil, & F Larra. (1975). [Radioprotective action of N-acetyl p. aminophenol in the mouse].. PubMed. 169(3). 511–4. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by D. Nagel Breakdown of academic impact, for papers by B.M.J. Cantwell Breakdown of academic impact, for papers by Paolo De Giuli Breakdown of academic impact, for papers by Kenneth Newkirk Breakdown of academic impact, for papers by Michael P. Chu Breakdown of academic impact, for papers by S. J. Harland Breakdown of academic impact, for papers by P Cappelaere Breakdown of academic impact, for papers by Yujun Li Breakdown of academic impact, for papers by Stefan Madajewicz Breakdown of academic impact, for papers by Deborah Kilpatrick
Rankless by CCL
2026